Kinetics and persistence of anti-SARS-CoV-2 neutralisation and antibodies after BNT162b2 vaccination in a Swiss cohort.

Sosic, Lara; Paolucci, Marta; Duda, Agathe; Hasler, Fabio; Walton, Senta M; Kündig, Thomas M; Johansen, Pål

Sosic, Lara; Paolucci, Marta; Duda, Agathe; Hasler, Fabio; Walton, Senta M; Kündig, Thomas M; Johansen, Pål.

Afiliação

Sosic L; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Paolucci M; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Duda A; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Hasler F; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Walton SM; Department of Dermatology, University of Zurich, Zurich, Switzerland.
Kündig TM; Research & Development, Saiba Biotech, Pfaeffikon, Switzerland.
Johansen P; Department of Dermatology, University of Zurich, Zurich, Switzerland.

Immun Inflamm Dis ; 10(3): e583, 2022 03.

Article em En | MEDLINE | ID: mdl-34965032

Assuntos

COVID-19; SARS-CoV-2; Anticorpos Antivirais; Vacina BNT162; COVID-19/prevenção & controle; Vacinas contra COVID-19; Humanos; Cinética; Suíça; Vacinação

Palavras-chave

BNT162b2; COVID-19; SARS-CoV-2; antibody response; mRNA vaccine; neutralisation assay

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Immun Inflamm Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google